Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled...

Area of Science:

• Neuroscience
• Psychology

Background:

• Microdosing psychedelics like psilocybin is popular for alleged cognitive benefits, including enhanced creativity.
• Anecdotal claims lack robust, double-blind, placebo-controlled scientific evidence.

Purpose of the Study:

• To quantitatively assess the effects of psilocybin microdosing on creativity.
• To investigate impacts on both convergent and divergent thinking in a controlled setting.

Main Methods:

• Three double-blind, placebo-controlled longitudinal trials were conducted.
• Data from 171 participants were pooled for a mega-analysis.
• Creativity was assessed using measures of convergent and divergent thinking.

Main Results:

• Active psilocybin microdosing increased the originality/fluency ratio, indicating improved divergent thinking quality.
• Originality scores were significantly higher in the microdosing group, especially when considering relative dosage.
• No effects were observed on convergent thinking or other divergent thinking metrics.

Conclusions:

• Psilocybin microdosing appears to specifically enhance the quality of divergent thinking.
• Controlling for placebo effects and prior psychedelic experience is crucial for accurate microdosing research.
• Findings underscore the importance of rigorous methodology in psychedelic research.